These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19750258)

  • 1. Safety of umbilical cord blood-derived mesenchymal stem cells (MSCs) following 5-azaserine induction and inhibition of human cardiac myocyte apoptosis by MSCs.
    Huang JL; Yang SX
    Saudi Med J; 2009 Sep; 30(9):1144-9. PubMed ID: 19750258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
    Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
    Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch signaling: a novel regulating differentiation mechanism of human umbilical cord blood-derived mesenchymal stem cells into insulin-producing cells in vitro.
    Hu YH; Wu DQ; Gao F; Li GD; Zhang XC
    Chin Med J (Engl); 2010 Mar; 123(5):606-14. PubMed ID: 20367990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating characterization of human umbilical cord blood-derived mesenchymal stem cells in vitro.
    Kang XQ; Zang WJ; Bao LJ; Li DL; Xu XL; Yu XJ
    Cell Biol Int; 2006 Jul; 30(7):569-75. PubMed ID: 16716607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promigratory activity of oxytocin on umbilical cord blood-derived mesenchymal stem cells.
    Kim YS; Kwon JS; Hong MH; Kim J; Song CH; Jeong MH; Cho JG; Park JC; Kang JC; Ahn Y
    Artif Organs; 2010 Jun; 34(6):453-61. PubMed ID: 20624160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells.
    Hong SH; Gang EJ; Jeong JA; Ahn C; Hwang SH; Yang IH; Park HK; Han H; Kim H
    Biochem Biophys Res Commun; 2005 May; 330(4):1153-61. PubMed ID: 15823564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood.
    Gang EJ; Jeong JA; Hong SH; Hwang SH; Kim SW; Yang IH; Ahn C; Han H; Kim H
    Stem Cells; 2004; 22(4):617-24. PubMed ID: 15277707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the immature characteristics of umbilical cord blood-derived mesenchymal stem cells and engraftment of hematopoietic stem cells in NOD/SCID mice.
    Yim YS; Noh YH; Kim DH; Lee MW; Cheuh HW; Lee SH; Yoo KH; Jung HL; Sung KW; Choi SJ; Oh WI; Yang YS; Koo HH
    Transplant Proc; 2010 Sep; 42(7):2753-8. PubMed ID: 20832581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction.
    Wang YQ; Wang M; Zhang P; Song JJ; Li YP; Hou SH; Huang CX
    Chin Med J (Engl); 2008 Nov; 121(22):2290-8. PubMed ID: 19080335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.
    Kern S; Eichler H; Stoeve J; Klüter H; Bieback K
    Stem Cells; 2006 May; 24(5):1294-301. PubMed ID: 16410387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of cell culture media conditions on the osteogenic differentiation of cord blood-derived mesenchymal stem cells.
    Hildebrandt C; Büth H; Thielecke H
    Ann Anat; 2009 Jan; 191(1):23-32. PubMed ID: 19121571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation.
    Friedman R; Betancur M; Boissel L; Tuncer H; Cetrulo C; Klingemann H
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1477-86. PubMed ID: 18022578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats.
    Chang YS; Oh W; Choi SJ; Sung DK; Kim SY; Choi EY; Kang S; Jin HJ; Yang YS; Park WS
    Cell Transplant; 2009; 18(8):869-86. PubMed ID: 19500472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin epithelial cells in mice from umbilical cord blood mesenchymal stem cells.
    Dai Y; Li J; Li J; Dai G; Mu H; Wu Q; Hu K; Cao Q
    Burns; 2007 Jun; 33(4):418-28. PubMed ID: 17467179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of neural potential of human umbilical cord blood-derived multipotent mesenchymal stem cells in response to a range of neurogenic stimuli.
    Zwart I; Hill AJ; Girdlestone J; Manca MF; Navarrete R; Navarrete C; Jen LS
    J Neurosci Res; 2008 Jul; 86(9):1902-15. PubMed ID: 18338797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priming of mesenchymal stem cells with oxytocin enhances the cardiac repair in ischemia/reperfusion injury.
    Kim YS; Ahn Y; Kwon JS; Cho YK; Jeong MH; Cho JG; Park JC; Kang JC
    Cells Tissues Organs; 2012; 195(5):428-42. PubMed ID: 21893931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryopreservation of umbilical cord blood-derived mesenchymal stem cells without dimethyl sulfoxide.
    Wang HY; Lun ZR; Lu SS
    Cryo Letters; 2011; 32(1):81-8. PubMed ID: 21468457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human-placenta-derived mesenchymal stem cells inhibit proliferation and function of allogeneic immune cells.
    Li C; Zhang W; Jiang X; Mao N
    Cell Tissue Res; 2007 Dec; 330(3):437-46. PubMed ID: 17899199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.